Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Class A Stock
-
Shares outstanding
-
115,244,363
-
Total 13F shares
-
67,739,467
-
Share change
-
+886,637
-
Total reported value
-
$4,178,223,997
-
Put/Call ratio
-
32%
-
Price per share
-
$61.67
-
Number of holders
-
338
-
Value change
-
+$52,788,626
-
Number of buys
-
161
-
Number of sells
-
152
Institutional Holders of GLOBUS MEDICAL INC - Class A Stock (GMED) as of Q1 2021
As of 31 Mar 2021,
GLOBUS MEDICAL INC - Class A Stock (GMED) was held by
338 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
67,739,467 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, JANUS HENDERSON GROUP PLC, WELLINGTON MANAGEMENT GROUP LLP, Capital Research Global Investors, STATE STREET CORP, RTW INVESTMENTS, LP, AXA S.A., Champlain Investment Partners, LLC, and GW&K Investment Management, LLC.
This page lists
338
institutional shareholders reporting positions in this security
for the Q1 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.